Evidence map›Paper›PMID 28352654›Full record

ArticleJCI insight2017

Abdul Waheed Khan, Mark Ziemann, Susan J Corcoran, Harikrishnan K N, Jun Okabe, Haloom Rafehi, Scott S Maxwell, Murray D Esler, Assam El-Osta

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JCI insight, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Epigenetics and Trained Immunity.Antioxidants & redox signaling · 2018
    Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Abdul Waheed KhanCentral Clinical School, Faculty of Medicine, Monash University, Victoria, Australia.
Mark ZiemannCentral Clinical School, Faculty of Medicine, Monash University, Victoria, Australia.
Susan J CorcoranBaker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia.
Harikrishnan K NCentral Clinical School, Faculty of Medicine, Monash University, Victoria, Australia.
Jun OkabeCentral Clinical School, Faculty of Medicine, Monash University, Victoria, Australia.
Haloom RafehiCentral Clinical School, Faculty of Medicine, Monash University, Victoria, Australia.
Scott S MaxwellCentral Clinical School, Faculty of Medicine, Monash University, Victoria, Australia.
Murray D EslerBaker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia.
Assam El-OstaCentral Clinical School, Faculty of Medicine, Monash University, Victoria, Australia.
Monash University · AUUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While strongly implicated in postural tachycardia syndrome (POTS), considerable controversy exists regarding norepinephrine transporter (

Indexed as

Gene SilencingEpigenesis, GeneticFemaleHeLa CellsHistone Deacetylase InhibitorsHumansMaleMethyl-CpG-Binding Protein 2MicroRNAsNorepinephrine Plasma Membrane Transport ProteinsPostural Orthostatic Tachycardia SyndromePromoter Regions, GeneticProtein BindingVorinostatHistone Deacetylase InhibitorsMECP2 protein, humanMethyl-CpG-Binding Protein 2MicroRNAsmirnlet7 microRNA, humanNorepinephrine Plasma Membrane Transport ProteinsSLC6A2 protein, humanVorinostat

Identifiers

PMID28352654
PMCPMC5358482
OpenAlexW2601165556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.